https://www.thebodypro.com/category/hiv-care-continuum/tag/conference-coverage
HIV Care Continuum

Conference Coverage

The Latest

Factors Associated With 10 Years of Continuous Viral Load Suppression on HIV Treatment Img

Factors Associated With 10 Years of Continuous Viral Load Suppression on HIV Treatment

There is no magic formula for achieving at least 10 years of continuous viral load suppression in people living with HIV. However, a poster presented at IDWeek 2014 shows several factors that may be associated with continuous viral load suppression....

Promo Image

Update on GSK744 and Monthly HIV Treatment or PrEP

For months, we've been excited about emerging data regarding GSK744 (also known as "744"), an investigational integrase inhibitor, close cousin of dolutegravir (Tivicay, DTG), with the potential for once-monthly injection dosing and promise in pre-ex...

HIV Pill Burden, Not Dosing Frequency, Appears to Affect Treatment Success Img

HIV Pill Burden, Not Dosing Frequency, Appears to Affect Treatment Success

New research suggests that HIV treatment success doesn't hinge on whether we take meds once a day vs. twice a day -- it's more about the number of pills we're being asked to pop.

Promo Image

Once-Daily Pills Improve Outcomes

People taking only one pill daily for their HIV treatment had less hospitalization and greater adherence than those taking multiple pills.

Those findings were presented by Cal Cohen, M.D., of the Community Research Initiative of New England, in Bost...

Smoothing Out the "HIV Treatment Cascade" in the U.S.: Research Explores Retention in Care and HIV Treatment Success Img

Smoothing Out the "HIV Treatment Cascade" in the U.S.: Research Explores Retention in Care and HIV Treatment Success

Despite all the talk about the "HIV treatment cascade" in the last year -- the steady drop that occurs between the number of people who are HIV positive and the number of people with an undetectable viral load -- there is still much to understand abo...

Promo Image

Enhanced Linkage-to-Care Strategy Helps HIV Patients Receive, Remain in Care, Study Shows

At the 19th Conference on Retroviruses and Opportunistic Infections (CROI) on Wednesday, Gabriel Chamie of the University of California, San Francisco "discussed outcomes in a routine linkage-to-care strategy versus and an enhanced strategy for accel...

Promo Image

High Adherence May Become Less Essential the Longer a Patient Maintains Viral Suppression on HAART, Findings Suggest

I'm David Bangsberg, at Massachusetts General Hospital and Harvard Medical School. This study is based on a group of people who are homeless or marginally housed in San Francisco, who are on antiretroviral therapy.1 We're measuring their adherence wi...

Promo Image

Lower Adherence May Precede Viral Load "Blips"

Although transient, low-level increases in viral load, also known as "blips," have been commonly observed in patients receiving antiretroviral therapy, studies have been inconsistent in their ascertainment of the significance of this phenomenon. Some...

Promo Image

Higher Degree of Medication "Forgiveness" in Use of Boosted Protease Inhibitors

Jonathan Shuter, M.D., and Julie Sarlo, P.A., in front of their poster.

In a widely cited study published in 2000, Paterson et al established that virologic response rates dropped dramatically when adherence levels were less than 95%.1 However, Pate...